Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E Clifton-Brown
Impact of National Criteria and Healthcare System Characteristics on Access to Biologic Dmards in Rheumatoid Arthritis in Europe
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
AB0432 Biologic Dmards Treatment Retention in Patients With Rheumatoid Arthritis According to the Moscow Arthritis Registry (MERA)
PMS33 Cost-Efficacy Analysis of Biologic Drugs in Combination With DMARDs in Patients With Active Rheumatoid Arthritis and Inadequate Response to Traditional DMARDs in Portugal – A Simplified Approach
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Quality of Life in Rheumatoid Arthritis Patients Taking Combination DMARDs
Journal of Medical Science And clinical Research
Review of Eight Pharmacoeconomic Studies of the Value of Biologic DMARDs Adalimumab, Etanercept, and Infliximab) in the Management of Rheumatoid Arthritis
Journal of Managed Care Pharmacy
Biologic Treatments for Rheumatoid Arthritis
Trends in Urology & Men's Health
Characteristics of Patients Starting Biologic Treatments for Rheumatoid Arthritis in the Real World: Systematic Review
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cardiovascular Risk in Rheumatoid Arthritis: Comparing TNF-α Blockade With Nonbiologic DMARDs
American Journal of Medicine
Medicine
Impact of Price Regulation of Biologic Therapies for Rheumatoid Arthritis in Colombia – A Cost Minimization Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Effect of Biologic Therapy on Radiological Progression in Rheumatoid Arthritis: What Does It Add to Methotrexate?
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
